Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moman A Mohammad

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
The Lancet. Digital Health|May 26, 2023
Advancing heart failure research using machine learningMoman A Mohammad
European Heart Journal. Acute Cardiovascular Care|January 3, 2022
Adding historical high-sensitivity troponin T results to rule out acute myocardial infarctionAndreas Roos, Moman A Mohammad, Ulf Ekelund, et al.
Journal of the American Heart Association|October 6, 2021
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART StudyAxel Wester, Moman A Mohammad, Göran Olivecrona, et al.
The Lancet Regional Health. Europe|September 12, 2024
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEARTHans Christian Rosén, Moman A Mohammad, Tomas Jernberg, et al.
European Heart Journal Open|April 3, 2023
Sex differences in potential triggers of myocardial infarctionAnneli Olsson, Moman A Mohammad, Rebecca Rylance, et al.
European Journal of Preventive Cardiology|February 6, 2025
Increased fluid accumulation, reduced physical activity and heart rate variability during national holidays in patients with cardiac implantable electronic devicesAnneli Olsson, Rebecca Rylance, Rasmus Borgquist, et al.
Plos One|April 26, 2019
Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)Anna M Nordenskjöld, Kai M Eggers, Tomas Jernberg, et al.
Platelets|November 26, 2016
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarctionMoman A Mohammad, Pontus Andell, Sasha Koul, et al.
Plos One|August 8, 2020
Association of acute myocardial infarction with influenza: A nationwide observational studyMoman A Mohammad, Johan Tham, Sasha Koul, et al.
Journal of the American Heart Association|April 22, 2026
Cardiovascular Outcomes in Patients With Deferred and Performed Coronary Revascularization Based on Intracoronary Physiology: A Systematic Review and Meta-AnalysisMarco Lombardi, Alejandro Travieso, Enrico Cerrato, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
The Lancet. Digital Health|May 26, 2023
Advancing heart failure research using machine learningMoman A Mohammad
European Heart Journal. Acute Cardiovascular Care|January 3, 2022
Adding historical high-sensitivity troponin T results to rule out acute myocardial infarctionAndreas Roos, Moman A Mohammad, Ulf Ekelund, et al.
Journal of the American Heart Association|October 6, 2021
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART StudyAxel Wester, Moman A Mohammad, Göran Olivecrona, et al.
The Lancet Regional Health. Europe|September 12, 2024
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEARTHans Christian Rosén, Moman A Mohammad, Tomas Jernberg, et al.
European Heart Journal Open|April 3, 2023
Sex differences in potential triggers of myocardial infarctionAnneli Olsson, Moman A Mohammad, Rebecca Rylance, et al.
European Journal of Preventive Cardiology|February 6, 2025
Increased fluid accumulation, reduced physical activity and heart rate variability during national holidays in patients with cardiac implantable electronic devicesAnneli Olsson, Rebecca Rylance, Rasmus Borgquist, et al.
Plos One|April 26, 2019
Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)Anna M Nordenskjöld, Kai M Eggers, Tomas Jernberg, et al.
Platelets|November 26, 2016
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarctionMoman A Mohammad, Pontus Andell, Sasha Koul, et al.
Plos One|August 8, 2020
Association of acute myocardial infarction with influenza: A nationwide observational studyMoman A Mohammad, Johan Tham, Sasha Koul, et al.
Journal of the American Heart Association|April 22, 2026
Cardiovascular Outcomes in Patients With Deferred and Performed Coronary Revascularization Based on Intracoronary Physiology: A Systematic Review and Meta-AnalysisMarco Lombardi, Alejandro Travieso, Enrico Cerrato, et al.
Pageof 6